1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MADRIGAL PHARMACEUTICALS INC
Madrigal Pharmaceuticals Inc XNAS: MDGL

Madrigal Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver f...

Read More
294.02 -0.38 (-0.13%)
46.55% Gain from 52W Low
76,070
XNAS Volume

XNAS 30 Jul, 2025 10:43 AM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Madrigal Pharmaceuticals Inc is on 07 Aug 2025 for the purpose of Madrigal Pharmaceuticals Inc Second Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
7.3 / 100
Momentum Score
Technically Neutral
43.8 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
425
1Yr Price target upside is 45%
14 analysts

8

S

10

W

3

O

1

T

SWOT Analysis

Madrigal Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..